Pfizer COVID-19 vaccine safe for younger kids -data

Pfizer and BioNTech said on Monday a lower dose of their COVID-19 vaccine induced a robust immune response in 5 to 11 year olds, and they plan to ask for authorization to use the vaccine in children in that age range in the United States, Europe and elsewhere as soon as possible. This report produced by Jillian Kitchener.

Multimedia

Most Popular Videos